semaglutide select Trial: Cuts Major CVD Risk by 20% in Overweight/Obese Adults Without Diabetes SELECT TRIAL , SEMAGLUTIDE AND

10.1016/j.cmet.2013.04.008 [DOI] [PubMed] [Google Scholar] 6.Sun L, Zheng ZM, Shao CS, Zhang ZY, Li MW, Wang L, Wang H, Zhao GH, Wang P (2022) Rational design by structural biology of industrializable, long-acting antihyperglycemic GLP-1 receptor agonists

Huang ES, Meigs JB, Singer DE

With respect to cognitive function, choline is needed for myelination of nerves and is a precursor for acetylcholine an important neurotransmitter involved in muscle action, memory, and other functions

While GLP-1 and shortness of breath are not typically linked in FDA prescribing information, some patients report respiratory symptoms during treatment